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Expansion of a polyglutamine (polyQ) tract in the Huntingtin (Htt) protein causes Huntington’s disease (HD), a
fatal inherited neurodegenerative disorder. Loss of the normal function of Htt is thought to be an important
pathogenetic component of HD. However, the function of wild-type Htt is not well defined. Htt is thought to be
a multifunctional protein that plays distinct roles in several biological processes, including synaptic trans-
mission, intracellular transport and neuronal transcription. Here, we show with biochemical and live cell ima-
ging studies that wild-type Htt stimulates the transport of nuclear factor k light-chain-enhancer of activated
B cells (NF-kB) out of dendritic spines (where NF-kB is activated by excitatory synaptic input) and supports
a high level of active NF-kB in neuronal nuclei (where NF-kB stimulates the transcription of target genes).
We show that this novel function of Htt is impaired by the polyQ expansion and thus may contribute to
the etiology of HD.
INTRODUCTION
Huntington’s disease (HD) is an autosomal dominant neurode-
generative disorder caused by expansion of a CAG trinucleo-
tide repeat in the huntingtin (HTT) gene, which translates into
an abnormally long polyglutamine (polyQ) tract in the
Huntingtin (Htt) protein (1). HD is characterized by late
onset motor, cognitive and psychiatric disturbances that
progress to death. Clinical symptoms are accompanied by
neuronal dysfunction and loss, particularly in the cerebral
cortex and corpus striatum (2).
It is well established that wild-type Htt is neuroprotective
(3–6) and that loss of the normal function of Htt can contrib-
ute to the HD phenotype (7–9). Nonetheless, the normal func-
tion of Htt remains poorly defined.
Htt has been separately implicated in at least three distinct
cellular processes (10): neuronal transcription, intracellular
transport and synaptic transmission. Of these three, the role
of Htt as a modulator of neuronal transcription is particularly
well documented. For example, wild-type Htt interacts with
transcription factors such as neurogenic differentiation
[NeuroD (11)] and RE1-silencing transcription factor/neuron-
restrictive silencer factor [REST/NRSF (12,13)] to promote
the establishment and maintenance of neuron-specific
transcriptional programs, which are critical for neuronal devel-
opment and survival. Wild-type Htt also interacts with nuclear
factor k light-chain-enhancer of activated B cells [NF-kB
(14)] that has been recently implicated in neural-specific func-
tions (15), including synaptic plasticity, neuroprotection and
activity-dependent brain-derived neurotrophic factor (BDNF)
expression (16–19). In non-neuronal cells, NF-kB is normally
kept in an inactive state outside the nucleus; however, in
neurons, basal glutamatergic transmission constitutively acti-
vates NF-kB (20,21). Of all the transcription factors that
respond to excitatory synaptic input, NF-kB is the only one
yet shown to be activated locally inside synapses (21,22). Fol-
lowing its activation, NF-kB is retrogradely transported along
dendrites to the soma where it is imported into the nucleus
(21,23). It had not been previously known whether there is a
relationship between binding of Htt to NF-kB and activation
of NF-kB at synapses or transport of NF-kB from the
synapse to the nucleus.
A second process in which Htt has been suggested to play a
role is intracellular transport. Specifically, Htt has been shown
to interact with cytosplasmic dynein, a motor protein that
drives cargoes along microtubular tracks toward the minus
end (24). Wild-type Htt binds to dynein in a complex with
dynactin and Htt-associated protein-1 (HAP1) to facilitate
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the transport of vesicles and mitochondria (24–27). The polyQ
expansion interferes with this function of Htt and causes
slower intracellular transport of vesicles and mitochondria
(25–27). Retrograde transport of NF-kB along dendrites
toward the nucleus is mediated by cytoplasmic dynein (28),
but a role for Htt in this process had not been previously
investigated.
Finally, the notion that Htt may be involved in synaptic
transmission arose from the fact that the proline-rich domain
of Htt binds to the SH3 domain of PSD-95 (29). PSD-95 is
a neuronal scaffold protein (30) that links synaptic glutamate
receptors, cell adhesion molecules, signal transducing
enzymes and cytoskeletal elements in the PSD, an intricate
protein complex located beneath the plasma membrane of den-
dritic spines at the point of contact with the axon terminal
(31). The biological significance of the binding of Htt to
PSD-95 remains unclear (32).
Here, we report a new functional role of Htt in the transport
of NF-kB from the synapse to the nucleus that involves all
three of these proposed cellular functions of Htt in an inte-
grated biological process. We show that transport of NF-kB
out of dendritic spines and its activity in neuronal nuclei is
reduced by the HD mutation and thus may contribute to the
etiology of HD.
RESULTS
Htt and NF-kB are present in the PSD fraction
PSD-95 and Htt have been shown to interact in brain lysates
(29), and PSD-95 is highly enriched in both the PSD fraction
and in the intact PSD in vivo (30,33,34). In contrast, Htt has
a broad subcellular distribution (35). Therefore, we asked
whether the interaction with PSD-95 causes a portion of Htt
to localize to the PSD fraction. We measured the content of
Htt in subcellular fractions obtained from adult rat forebrains
(Fig. 1A and B). The results confirm that Htt has a broad sub-
cellular distribution and is found in the cytosolic (S3), micro-
somal (P3), synaptosomal (SS) and clathrin-coated vesicle
(CCV) fractions. HAP1, a protein that has previously been
found to bind to Htt, has the same distribution (36,37).
However, in addition to their localization in these fractions,
we found that both Htt and HAP1 are present in the PSD
fraction.
We applied two additional tests to confirm that Htt interacts
directly with PSD-95 in the PSD fraction. The PSD fraction
can be separated into a high-density component devoid of
lipid and a low-density component that corresponds to neur-
onal lipid rafts (38,39). We found that Htt and HAP1 are
located only in the high-density component where they
co-migrate with a portion of PSD-95 (Fig. 1C). We were
also able to coimmunoprecipitate Htt and PSD-95 from a
PSD fraction that had been partially solubilized in alkaline
deoxycholate as described in Blahos and Wenthold (40),
Figure 2A. In contrast, synGAP, a protein that is highly
enriched in the PSD (41) and associates with PSD-95 but
not Htt, does not coimmunoprecipitate with Htt. These
results support the hypothesis that the PSD is the subcellular
locale where Htt and PSD-95 interact.
We estimated the equilibrium dissociation constant (Kd) for
the interaction between Htt and PSD-95 by measuring the
affinity of a recombinant exon 1 fragment of wild-type Htt for
full-length recombinant PSD-95 in a modified enzyme-linked
sorbent assay (ELSA; Fig. 2B). The measured Kd of 0.8+
0.12 mM indicates that Htt and PSD-95 interact with a biologi-
cally meaningful affinity in the same range (0.1–8 mM) as
other SH3/proline-rich domain-mediated interactions (42).
Because wild-type Htt has been reported to bind to the p50
subunit of NF-kB (14), we investigated whether NF-kB is also
found in the PSD fraction. Active NF-kB has been recovered
from synaptosomal preparations after stimulation with gluta-
mate (21,22). However, synaptosomes contain both pre- and
postsynaptic compartments and it has not been established
whether synaptic activation of NF-kB is a pre- or a postsynaptic
event. Although NF-kB and inhibitor of kB (I-kB) have been
visualized in the PSD by electron microscopic immunocyto-
chemistry (43), their presence in the PSD fraction had not
been established. We used a mini-prep method that we devel-
oped for rapid and convenient purification of the PSD fraction
from a single mouse forebrain (Fig. 3A) to examine this issue.
We found that both the p50 and p65 subunits of NF-kB are
indeed present in the PSD fraction (Fig. 3B). Moreover, we
found that the phosphorylated form of I-kBa is highly enriched
in the PSD fraction compared with homogenate and synapto-
somes. Phosphorylation of I-kBa initiates the process of
NF-kB activation. Interestingly, we also found that I-kB is a
substrate for Ca2+/calmodulin-dependent protein kinase II
(CaMKII), a major protein kinase in the PSD (Supplementary
Material, Fig. S1). Thus, the PSD may be a site at which
NF-kB is preferentially activated in the synapse.
The HD mutation impairs localization of Htt
in the PSD fraction
Sun et al. (29) reported that the HD mutation interferes with
binding of Htt to PSD-95. If binding to PSD-95 is important
for localization of Htt to the PSD, then the HD mutation
should reduce the association of Htt with the PSD fraction.
To test whether this is true, we used the PSD mini-prep
method to compare the molecular composition of the PSD
fraction between individual mouse mutants. We measured
the amounts of Htt, the Htt-associated protein HAP1 and
several other proteins known to be enriched in the PSD frac-
tion at various ages in wild-type and HD knock-in mice in
which an expanded stretch of 140 CAG repeats is inserted
into the first exon of the mouse Htt gene by homologous
recombination (44,45). The HD mutation reduced the
amount of Htt in the PSD fraction to 45+ 6 and 35+ 4%
of that in young adult and aged wild-type control mice
(6 months and 2 years of age, respectively, n ¼ 4) (Fig. 4A
and B). The Htt-associated protein HAP1 showed an opposite
trend toward increased levels in the PSD fraction from HD
knock-in mice, although the trend was not statistically signifi-
cant. The latter result suggests that HAP1 may anchor itself to
the PSD independently of its interaction with Htt, perhaps via
its interaction with other PSD proteins such as Kalirin-7
(46,47). The levels of synGAP, CaMKII and PSD-95 were
not significantly altered in the PSD fraction from HD
knock-in mice.
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Taken together, our data demonstrate that a portion of neur-
onal Htt localizes to the PSD fraction where it interacts with
PSD-95. The HD mutation impairs localization of Htt in the
PSD fraction, suggesting that any functional role of Htt in
the PSD may also be impaired by the HD mutation.
Htt interacts preferentially with active NF-kB
The localization of both Htt and NF-kB in the PSD fraction led
us to investigate whether Htt might play a role in the activation
of NF-kB inside synapses upon stimulation of glutamate recep-
tors (21). In the absence of stimuli, NF-kB is kept in an inactive
state outside the nucleus by binding to an inhibitory protein of
the I-kB family, which masks the nuclear localization signal
(NLS) and the DNA-binding domain of NF-kB. Phosphoryl-
ation of I-kB at specific serine residues (for instance, serines
32 and 36 of I-kBa) directs I-kB to the ubiquitin-proteasome
system (UBS) to be degraded and activates NF-kB by releasing
it for nuclear import and DNA binding (48).
We considered two hypothetical models for a role of Htt in
the postsynaptic activation of NF-kB. Htt might interact with
inactive NF-kB and anchor it to the PSD by binding to
PSD-95, facilitating the activation of NF-kB by the signal
transduction machinery associated with glutamate receptors.
Alternatively, Htt might interact preferentially with active
NF-kB and facilitate its transport from the PSD to the
nucleus by binding to the dynein–dynactin motor complex.
As a first step to distinguish between these two hypotheses,
we asked whether Htt interacts with active or inactive NF-kB.
Htt has previously been shown to bind to the p50 subunit of
NF-kB in HeLa cells (14). The synaptic form of NF-kB is a
heterodimer composed of p50 and p65 subunits; therefore,
we first tested whether Htt can also interact with the p65
subunit. We found that Htt coimmunoprecipitates with p65
from HeLa cell lysates (Fig. 5A, lane 1). To test whether
this interaction is changed by activation of NF-kB, we
treated the HeLa cells with tumor necrosis factor-a (TNF-a)
to activate NF-kB prior to immunoprecipitation. The treatment
increased the amount of p65 immunoprecipitating with Htt by
193+ 35% relative to the untreated controls (n ¼ 3) (Fig. 5A,
compare lane 1 with lane 4). Quantitation was performed
by fluorescent immunoblot as described in Materials and
Methods. These data suggest that Htt binds preferentially to
the activated form of NF-kB.
As part of the process of activation of NF-kB, I-kB is
degraded, exposing the NLS of NF-kB which then binds to
a member of the importin-a family (49). Members of the
importin-a family bind to a variety of NLS-containing pro-
teins and form a complex with importin-b1. The importin
complex mediates the translocation of these proteins from
the cytoplasm into the nucleus through the nuclear pore
complex (50). Therefore, to further probe the state of
Figure 1. Htt is present in the PSD fraction. (A) Schematic diagram of the procedures used for subcellular fractionation of adult rat forebrains. (B) Representative
immunoblot (n ¼ 4) of subcellular fractions (40 mg of total protein) prepared from adult rat forebrains by differential and density-gradient centrifugation. PSD-95
(a postsynaptic density marker), clathrin heavy chain (CHC, a clathrin-coated vesicle marker), Huntingtin (Htt) and Huntingtin-associated protein 1 (HAP1) were
detected as described in Materials and Methods. (C) Representative immunoblot (n ¼ 2) of sequential fractions (40 ml), collected beginning from the bottom of
the tube, after ultracentrifugation of a PSD fraction through an OptiPrep (Axis-Shield) density gradient (lanes 1–8, from high to low density). PSD-95, Htt and
HAP1 were detected as described in Materials and Methods. H, forebrain homogenate; S1, post-nuclear supernatant; P1, nuclear pellet; S2, medium speed super-
natant of S1; P2, crude synaptosomal pellet; SS, purified synaptosomal fraction derived from P2; SUP, high-speed supernatant of SS extracted with Triton X-100;
PSD, postsynaptic density fraction; S3, cytosol; P3, microsomal pellet; CCV, clathrin-coated vesicles derived from P3.
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activation of NF-kB in Htt immunoprecipitates, we tested for
the presence of I-kBa, which would be in the complex only if
NF-kB is inactive, and for importin-a, which would be present
only if NF-kB is active.
We decided to test specifically for importin-a2, because its
localization and behavior in neurons is very similar to that of
NF-kB. For example, it has been shown to localize to the PSD
(51 and Fig. 5B) and to translocate from the synapse to the
nucleus upon stimulation of glutamate receptors (51). We
found that importin-a2 coimmunoprecipitates with NF-kB
(Fig. 5C) and with Htt and p65 from HeLa cell lysates
(Fig. 5A), whereas I-kBa does not. Furthermore, importin-a2
was detectable in the immunoprecipitates only when NF-kB
was activated by treatment with TNF-a (Fig. 5A, compare
lanes 2 and 5). The level of importin-a2 in lane 2 was not stat-
istically significantly different from the control level in lane 3,
whereas the level in lane 5 was significantly greater than the
control level in lane 6 (P ¼ 0.02, n ¼ 3). These results
strengthen the conclusion that Htt preferentially interacts
with the activated form of NF-kB.
Both loss of Htt function and the HD mutation slow
the rate of movement of NF-kB out of activated
dendritic spines
A general role of wild-type Htt in stimulating intracellular trans-
port events mediated by the dynein–dynactin motor complex is
well established. For example, downregulation of Htt
expression by RNAi or deletion of Htt by conditional gene tar-
geting causes substantially slower intracellular transport of ves-
icles and mitochondria (24–26). Htt appears to stimulate
retrograde transport of various cargoes through its binding to
dynein intermediate chain (24) and to HAP1 (25), which inter-
acts directly with the p150Glued subunit of dynactin (52,53).
Our finding that Htt interacts preferentially with the acti-
vated form of NF-kB (Fig. 5A) and the fact that the
dynein–dynactin motor complex is required for the retrograde
transport of NF-kB in dendrites upon stimulation of glutamate
receptors (28), prompted us to investigate whether Htt plays a
role in the transport of NF-kB from dendritic spines to the
nucleus. To visualize movement of NF-kB out of dendritic
spines, we transfected mature neurons cultured for 14 days
in vitro with the p65 subunit of NF-kB tagged with a photoac-
tivatable variant of GFP [paGFP–p65 (54)] and used two-
photon laser excitation to photoactivate paGFP–p65 within a
single spine (55), Figure 6A. To determine the rate of activity-
dependent NF-kB movement out of dendritic spines, we first
bathed the neurons in tetrodotoxin (TTX) for 12 h and then
removed the TTX to initiate action potentials. After TTX
washout, we photoactivated the paGFP–p65 in single spines.
We then made repeated time-lapse measurements of fluor-
escence intensity within each targeted spine and fitted the
decay curve with a single exponential to obtain the half-life
of fluorescence decay. To correct for the decay of fluorescence
caused by photobleaching, we repeated the measurements in
the same neurons after chemical fixation.
Figure 2. Htt interacts with PSD-95 in the PSD fraction. (A) Representative
immunoblot of proteins immunoprecipitated (IP) from a solubilized PSD frac-
tion prepared from adult rat forebrains (INPUT, 5% of total input; 20 mg of
total protein) by incubation with protein G magnetic beads pre-coated with
an antibody against Htt (+) or with an isotype control antibody (2). Hunting-
tin (Htt), synGAP and PSD-95 were detected as described in Materials and
Methods. The experiment was performed twice under the conditions shown
and twice under slightly different detergent conditions with the same result
(n ¼ 4). (B) Binding of full-length PSD-95 to the N-terminal portion of Htt
corresponding to exon 1, immobilized in a microplate well. Data (n ¼ 3)
were obtained by a modified enzyme-linked sorbent assay (ELSA) in which
the integrated intensity of the fluorescence emitted by a fluorophore-labeled
antibody against PSD-95 is measured with a fluorescence microplate reader.
Figure 3. NF-kB is present in the PSD fraction. (A) Representative immuno-
blot (n ¼ 4) of subcellular fractions (20 mg of total protein) prepared from a
single adult mouse forebrain by differential and density gradient centrifu-
gation. PSD-95 (a postsynaptic marker) and Synaptophysin (a presynaptic
marker) were detected as described in Materials and Methods. M, molecular
weight marker; H, forebrain homogenate; SS, purified synaptosomal fraction
derived from H; PSD, postsynaptic density fraction derived from SS extracted
with Triton X-100. (B) Representative immunoblot (n ¼ 4) of subcellular frac-
tions (40 mg of total protein) prepared from a single adult mouse forebrain by
differential and density gradient centrifugation. The p65 and p50 subunits of
NF-kB, and I-kBa phosphorylated on serine 32 (I-kBa-pS32) were detected
as described in Materials and Methods. H, forebrain homogenate; SS, purified
synaptosomal fraction derived from H; PSD, postsynaptic density fraction
derived from SS extracted with Triton X-100.
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We first compared the activity-dependent movement of
NF-kB out of spines in live cortical pyramidal neurons cul-
tured from mice with a conditional knock-out of Htt targeted
to pyramidal neurons (4) and in neurons from control mice
lacking the Cre transgene. After correction for photobleach-
ing, the half-life for movement of NF-kB out of dendritic
spines in control neurons was 21+ 5 s (Fig. 6B and C).
In neurons from which Htt was deleted, the half-life was
58+ 11 s, more than double that of controls (Fig. 6B and
C). These results demonstrate that wild-type Htt stimulates
the rate of activity-dependent movement of NF-kB out of
dendritic spines.
The HD mutation is known to impair the ability of Htt to
stimulate intracellular transport of organelle cargoes carried
by the dynein–dynactin motor complex (25,26). Therefore,
we next determined whether the HD mutation also interferes
with the activity-dependent movement of NF-kB out of
dendritic spines. We compared the transport of NF-kB in wild-
type neurons and neurons isolated from HD knock-in mice.
After correction for photobleaching, the half-life for move-
ment of NF-kB out of dendritic spines in HD neurons was
75+ 7 s compared to 36+ 3 s in wild-type neurons
(Fig. 6D and E). These results indicate that the HD mutation
is sufficient to slow the rate of NF-kB movement out of den-
dritic spines.
To confirm that this movement is driven by synaptic
activity, we measured the transport of NF-kB in wild-type
neurons before and after TTX washout and found, as expected,
that the half-life of fluorescence decay was 230+ 24 s before
TTX washout and 37+ 1 s after (n ¼ 2, data not shown).
Both loss of Htt function and the HD mutation reduce
the concentration of active NF-kB in neuronal nuclei
Because excitatory synaptic input is the major physiological
inducer of NF-kB activity in neurons (20,21), we hypothesized
that loss of Htt function should reduce the movement of active
NF-kB along the dendrite toward the soma, ultimately redu-
cing the amount of active NF-kB in the nucleus. We were
not able to track the movement of NF-kB after it left the den-
dritic spine, because fluorescent NF-kB rapidly disperses in
the dendrite and does not concentrate in large transport par-
ticles or vesicles. Therefore, we investigated whether the
transport defects that we observe at the synapse correlate
with decreased levels of active NF-kB in the nucleus. We pre-
pared extracts of a neuronal nuclear fraction from forebrains of
4-month-old Htt knock-out mice, 6-month-old HD knock-in
mice and the corresponding controls. The amount of active
NF-kB in the extracts was measured by a DNA pull-down
assay. We used double-stranded DNA oligonucleotides con-
taining a known consensus binding site for the activated
form of NF-kB, termed a kB site. Oligonucleotides containing
a mutated kB site that does not bind NF-kB were used as nega-
tive control. Htt knock-out mice had reduced levels of active
NF-kB (24+ 8% of controls, n ¼ 2) in the nuclei of forebrain
neurons (Fig. 7A). An even more severe reduction was
observed in HD knock-in mice (11+ 3% of controls, n ¼ 2;
Fig. 7B). The total NF-kB was also reduced in the nuclear
fraction, albeit not as substantially as active NF-kB (75+
2% of controls in Htt knock-out mice and 63+ 1% of controls
in HD knock-in mice, n ¼ 2; Fig. 7A and B, respectively).
These data are consistent with the prediction that in neurons
from Htt knock-out and HD knock-in mice, impaired transport
of NF-kB from distal synaptic sites will result in a reduced
level of active NF-kB in the nucleus.
DISCUSSION
The major finding reported here is that Htt stimulates the rate
of activity-dependent transport of NF-kB out of dendritic
spines, where NF-kB is tonically activated by ongoing synap-
tic activity (20,21). Furthermore, we have shown that the HD
mutation interferes with this novel function of Htt, suggesting
that impaired transport of NF-kB from the synapse to the
Figure 4. The HD mutation impairs localization of Htt in the PSD fraction.
(A) Mean amount of indicated proteins in PSD fractions (40 mg of total
protein) prepared from forebrains of 6-month-old (6 mo) HD knock-in (HD)
mice, plotted as percentage relative to wild-type control (WT) mice (n ¼ 4
non-sex matched, littermate pairs). Protein quantitation was performed by
immunoblotting as described in Materials and Methods. Representative blots
are shown below the graph. Error bars represent SEM. ∗P , 0.05, ∗∗P ,
0.01; two-tailed paired t-test. (B) Same as (A) but using 2-year-old (2 yr)
mice (n ¼ 4 non-sex matched, littermate pairs).
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nucleus may contribute to the etiology of HD. Consistent with
this proposed function of Htt, we have shown that it is present
in the PSD fraction where it interacts with PSD-95, a major
PSD scaffold protein. The polyQ expansion interferes with
the localization of Htt to the PSD fraction, presumably
because of its decreased affinity for PSD-95 (29). We also
confirmed that NF-kB and I-kB are located in the PSD. Our
finding that I-kB is a substrate for Ca2+/calmodulin-dependent
protein kinase II (CaMKII), a major protein kinase in the PSD
(Supplementary Material, Fig. S1), suggests a potential mol-
ecular mechanism by which stimulation of synaptic glutamate
receptors might rapidly and locally activate NF-kB in the
PSD. We also found that Htt associates preferentially with
the activated form of NF-kB and importin-a2, which is
involved in the translocation of active NF-kB across the
nuclear pore into the nucleus (49). Wild-type Htt is believed
to be a multifunctional protein and it has been implicated in
several distinct cellular processes, including synaptic trans-
mission, intracellular transport and neuronal transcription.
Our findings show that all three of these apparently indepen-
dent processes are facets of the role that Htt plays in the
activity-dependent transport of the transcription factor
NF-kB out of dendritic spines.
A steady flow of active NF-kB from distal synaptic sites to
the nucleus is needed to sustain the high basal levels of nuclear
NF-kB activity observed in neurons (21,28). Loss of Htt
function, resulting from a null mutation or the polyQ expan-
sion, could limit the amount of active NF-kB in the nucleus,
as we have observed in forebrain neurons from Htt knock-out
and HD knock-in mice. This low basal level of nuclear NF-kB
activity in neurons could result in weakened neuroprotective
transcriptional responses associated with NF-kB and therefore
contribute to the etiology of HD.
A myriad of molecular and cellular dysfunctions have been
observed in models of HD. Therefore, it is possible that the
low constitutive nuclear NF-kB activity that we observed in
forebrain neurons of HD mice is caused by a different impair-
ment unrelated to Htt-mediated transport of NF-kB from the
synapse to the nucleus. For example, the HD mutation could
lead to defective activation of NF-kB in synapses by altering
synaptic transmission (56,57) or by inhibiting UBS-mediated
proteolysis of I-kB in the PSD (58). In general, however,
these dysfunctions are much milder and more slowly progres-
sing in full-length Htt knock-in mouse models of HD than in
models generated by overexpression of very long polyQ tracts
in the context of very short N-terminal fragments of Htt. For
example, baseline synaptic transmission was found to be
normal in HD knock-in mice up to 4 months of age (59). In
addition, reduced UBS-mediated proteolysis has been observed
in HD knock-in mice only after 1 year of age (58).
Figure 5. Htt interacts preferentially with active NF-kB. (A) Representative immunoblot of proteins immunoprecipitated (IP) from HeLa cell lysates (INPUT,
10% of total input; 40 mg of total protein) by incubation with protein G magnetic beads pre-coated with antibody against Htt (+, lanes 1–2 and 4–5) or with an
isotype control antibody (2, lanes 3 and 6). The p65 subunit of NF-kB, total I-kBa, Importin-a2 (Imp-a2) and mouse IgG (IgG H) were detected as described in
Materials and Methods. Lanes 2–3 and 5–6 contain precipitates from beads covalently bound to Htt and control antibodies by a cross-linking reagent to enable
elution of the immunoprecipitated proteins without contamination by heavy and light chains of IgG. Lanes 1–3 (2TNF-a) contain precipitates from lysates of
cells that were not treated TNF-a. Lanes 4–6 (+TNF-a) contain precipitates from lysates of cells that had been treated with TNF-a to activate NF-kB, as
described in Materials and Methods. The experiment was performed twice under the conditions shown and once under slightly different detergent conditions
with the same result (n ¼ 3). (B) Immunoblot of subcellular fractions (40 mg of total protein) prepared from a single adult mouse forebrain by differential
and density gradient centrifugation. Importin-a2 (Imp-a2) was detected in the PSD as described in Materials and Methods and as previously shown by Thompson
et al. (51). H, forebrain homogenate; SS, purified synaptosomal fraction derived from H; PSD, postsynaptic density fraction derived from SS extracted with
Triton X-100; MW, molecular weight marker. (C) Representative immunoblot of proteins immunoprecipitated (IP) from lysates of HeLa cells that had been
treated with TNF-a as described in (B; INPUT, 10% of total input; 40 mg of total protein) by incubation with protein G magnetic beads pre-coated with antibody
against Imp-a2 (+) or isotype control antibody (2). The p65 subunit of NF-kB was detected as described in Materials and Methods. The immunoblot was
performed twice under the conditions shown and once under slightly different detergent conditions with the same result (n ¼ 3). MW, molecular weight markers.
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Our proposed role of Htt in the transport of NF-kB from the
synapse to the nucleus is also supported by the fact that we see
the correlation of defective transport of NF-kB and reduced
level of NF-kB in neuronal nuclei in both HD knock-in and
Htt knock-out mice. Of all dysfunctions reported in HD
mutant mice, only defective transport of membranous orga-
nelles (26) and abnormal nuclear activity of the transcription
factor REST/NRSF (13) have also been reported in Htt knock-
out mice. Interestingly, abnormal levels of REST/NRSF
activity in the nucleus could also be the consequence of defec-
tive intracellular transport of REST/NRSF mediated by the
dynein–dynactin motor complex (60).
Whether NF-kB acts in the brain as a pro-survival or
pro-apoptotic agent has been the topic of much debate. In
recent years, however, it has become increasingly clear that
tonic activation of NF-kB in neurons, driven by physiological
levels of ongoing synaptic activity, is neuroprotective (17,18).
In contrast, activation of NF-kB in glial cells, particularly in
the context of acute brain injury, is neurotoxic (15). Activity-
dependent BDNF expression is one component of the neuro-
protective transcriptional response mediated by NF-kB in
neurons (61,62) and is particularly relevant here because
loss of BDNF expression has been proposed to play a critical
role in the etiology of HD (7,8). In addition to loss of neuro-
protection and activity-dependent BDNF expression, low
levels of NF-kB activity in neurons could also lead to impair-
ment of cognitive functions (63,64), a common feature of
chronic neurodegenerative disorders such as HD.
In neurons, signals received at distal sites in axons and den-
drites must be retrogradely transported to the nucleus to alter
gene expression during neuronal development, synaptic plas-
ticity and in response to neuronal injury. Recent studies
Figure 6. Both loss of Htt function and the HD mutation slow the rate of
movement of NF-kB out of activated dendritic spines. (A) Dendritic
segment of a cultured cortical pyramidal neuron (15 days in vitro) that was
transiently transfected with mCherry (red channel, left) and with photoactiva-
table green fluorescent protein fused to the p65 subunit of NF-kB (paGFP–
p65; green channel, right), as described in Materials and Methods. Circles
indicate dendritic spines in which paGFP–p65 was photoactivated by targeted
two-photon laser radiation. The green channel on the right shows the fluor-
escence of paGFP–p65 before (top) and after (bottom) photoactivation. (B)
Time course of paGFP–p65 fluorescence after photoactivation in single den-
dritic spines of live cortical pyramidal neurons derived from Htt knock-out
(red dots, KO) and control (yellow dots, CTRL) mice, in a representative time-
lapse experiment. Decay of paGFP–p65 fluorescence due to photobleaching
(black dots, BL) was measured as the time course of paGFP–p65 fluorescence
after photoactivation in single dendritic spines of the same neurons after
chemical fixation. paGFP–p65 fluorescence is plotted over time (t) as
percent of fluorescence at the time of photoactivation (F/F0). (C) Mean half-
life (t1
2
) of paGFP–p65 fluorescence decay (fitted with a single exponential
and corrected for photobleaching) after photoactivation in single dendritic
spines (n ¼ 3 non-sex matched, littermate pairs [21/59 neurons/spines]).
(D and E) Same as (B) and (C), except that neurons were prepared from
HD knock-in (HD) and wild-type control (WT) mice (n ¼ 5 non-sex
matched, littermate pairs [32/93 neurons/spines]). Error bars represent SEM.
∗P, 0.05, ∗∗P , 0.01; two-tailed paired t-test.
Figure 7. Both loss of Htt function and the HD mutation reduce the concen-
tration of active NF-kB in neuronal nuclei. Representative immunoblots of
active NF-kB purified from neuronal nuclear extracts (100 mg of total
protein) by incubation with streptavidin magnetic beads pre-coated with bio-
tinylated double-stranded DNA oligonucleotides containing the kB site (+)
or a negative control sequence (2). The p65 subunit of NF-kB and Lamin
A/C (nuclear markers) were detected as described in Materials and
Methods. Extracts (INPUT, 10% of total input; 10 mg of total protein) were
obtained from neuronal nuclear fractions prepared from forebrains of (A)
4-month-old Htt knock-out (KO) and control (CTRL) mice (n ¼ 2 non-sex
matched, littermate pairs) and (B) 6-month-old HD knock-in (HD) and wild-
type control (WT) mice (n ¼ 2 non-sex matched, littermate pairs). See text for
quantification of the immunoblots.
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indicate that importins may mediate the transport of active-
signaling cargoes, such as transcription factors and protein
kinases, from dendritic spines and axon terminals back to
the nucleus (65,66). For example, peripheral sensory neurons
respond to axonal injury by assembling a signaling complex
composed of an active-signaling cargo bound to a transport
complex composed of importin-a, importin-b1 and the
motor protein dynein. This signaling complex travels retrogra-
dely along microtubular tracks from the site of injury in the
periphery of the axon to the cell body where it elicits an adap-
tive transcriptional response (67,68).
We propose that Htt may serve a general role in neuronal
transport similar to that of importin-b1, but in the context of
synaptic transmission rather than axonal injury. Several
recent findings support this idea. First, the primary and
deduced secondary structures of Htt are similar to those of
importin-b1. Like importin-b1, Htt is predominantly com-
posed of repeated HEAT domains (14). This composition pre-
dicts a similar tertiary structure for the two proteins (69).
Second, Htt is located in the PSD, closer to the synapse than
importin-b1, which has a predominantly perinuclear localiz-
ation and cannot be detected in the PSD fraction (51).
Finally, we and others have found that importin-a2 (the
usual binding partner of importin-b1) and its cargo NF-kB
are both present in the PSD fraction (51) and interact with
Htt. Therefore, we suggest that Htt may play a role similar
to that of importin-b1 in the retrograde transport of
NLS-containing cargoes from synapses toward the nucleus.
The finding that a functional NLS is required for the retro-
grade transport of NF-kB in neurons and for the interaction
between NF-kB and the dynein–dynactin motor complex
(28) is consistent with this view. Thus, it would be worthwhile
to determine whether Htt functions like importin-b1 with
additional NLS-containing cargoes. Some of these, including
NeuroD and REST/NSRF, are already known to interact
with Htt (11–13).
A deeper understanding of the physiological function of
wild-type Htt and its role in sustaining neuroprotective tran-
scriptional homeostasis will inform the development of thera-
pies for HD. In particular, the normal roles of Htt in neurons
should be considered in the context of proposed cures based
on silencing of Htt gene expression in the brains of HD
patients.
MATERIALS AND METHODS
Animals
All procedures involving animals were carried out in accord-
ance with the NIH Guide for the Care and Use of Laboratory
Animals and were approved by the Institutional Animal Care
and Use Committee (IACUC) of the California Institute of
Technology. The HD 140Q knock-in mice are described in
Menalled et al. (44) and were bred to generate homozygous
mutants (HD) and wild-type littermate controls (WT). The
Htt R1ag5 knock-out mice are described in Dragatsis et al.
(4) and were bred to generate Hdhflox/2;Cre/+ mutants
(KO) and littermate controls lacking the Cre transgene
(CTRL). Rats (Sprague–Dawley) were obtained from Harlan
Laboratories.
Subcellular fractionation
S1 (post-nuclear supernatant), S2, P2 (crude synaptosomal
pellet), SS (purified synaptosomal fraction), SUP (‘One
Triton’ supernatant) and PSD (‘One Triton’ pellet) fractions
were obtained from adult rat forebrains as described in Cho
et al. (30) with minor modifications. S3 (cytosol) and P3
(microsomal pellet) fractions were obtained from the S2 frac-
tion by ultracentrifugation (150 000g) for 1.5 h at 48C. The
CCV fraction was obtained from the P3 fraction as described
in Velier et al. (35). Lipid rafts were obtained from the PSD
fraction as described in Ma et al. (39). To rapidly obtain the
PSD fraction from a single mouse forebrain, synaptosomes
were purified by differential and Percoll density gradient cen-
trifugation as described in Dunkley et al. (70), except that only
three layers of Percoll (GE Healthcare Life Sciences) were
used (5, 10 and 20%) and protease inhibitors (Complete
EDTA-free, Roche) were added to the buffers. Purified synap-
tosomes were then washed and resuspended in the PSD buffer
[40 mM Tris–HCl, pH 8.1, 1× protease inhibitor cocktail
(Roche, Complete EDTA-free)], extracted by adding 0.5%
Triton X-100 and stirring for 15 min at 48C, and centrifuged
(40 000g) for 40 min at 48C to obtain the PSD (‘One Triton’
pellet) fraction.
Expression vectors
We are grateful to Johannes A. Schmid (Medical University of
Vienna, Vienna, Austria) for the pEGFP–p65 plasmid, Roger
Y. Tsien (University of California, San Diego, CA, USA) for
the mCherry plasmid, George H. Patterson and Jennifer
Lippincott-Schwartz (National Institutes of Health, Bethesda,
MD, USA) for the PA-GFP plasmid. The p65 cDNA (from
the pEGFP-p65 plasmid) was cloned in frame and fused at
the C-terminus of the photoactivatable green fluorescent
protein (paGFP, from the PA-GFP plasmid) cDNA into the
phCMV1 vector backbone (Genlantis) to generate the pPA–
GFP–p65 plasmid. The mCherry cDNA (from the mCherry
plasmid) was cloned into the phCMV1 vector backbone
(Genlantis) to generate the phCMV1–mCherry plasmid.
DNA was purified using a plasmid maxi prep kit (QIAGEN,
EndoFree Plasmid Maxi Kit).
Cell culture and transfection
Cerebral cortices were dissected from the brain of mice at
embryonic day 15–16 and mechanically triturated in
ice-cold Hank’s balanced salt solution (GIBCO/Invitrogen,
Cat. No. 14170) supplemented with 10 mM HEPES (pH 7.2–
7.5) (GIBCO/Invitrogen) and 1 mM sodium pyruvate
(GIBCO/Invitrogen). Dissociated neurons and glial cells
were seeded on 24-well glass bottom plates (MatTek)
freshly coated with poly-D/L-lysine (Sigma-Aldrich) at
a density of 50 000 neurons/well and maintained in
Neurobasal medium (GIBCO/Invitrogen) supplemented with
2% B-27 (GIBCO/Invitrogen) and 0.5 mM GlutaMAX-I
(GIBCO/Invitrogen). Cultured neurons were transfected at
14 days in vitro using NeuroFECT (Genlantis) according to
manufacturer’s instructions, except that they were exposed
to NeuroFECT/DNA complexes for only 1 h, washed and
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maintained overnight in conditioned cell culture medium to
prevent neurotoxicity. Human cervix carcinoma (HeLa)
(ATCC, CCL-2) cells were cultured in DMEM GlutaMAX-I
medium (GIBCO/Invitrogen, Cat. No. 10569) supplemented
with 10% fetal bovine serum (HyClone), 0.1 mM non-essential
amino acids (GIBCO/Invitrogen) and 100 U/ml penicillin +
100 mg/ml streptomycin (GIBCO/Invitrogen). To stimulate
NF-kB activity, HeLa cells were incubated with recombinant
human TNF-a (R&D Systems) at a concentration of
20 ng/ml for 30 min.
Antibodies and immunoblotting
The sample total protein concentration was determined using a
bicinchoninic acid assay (Pierce) against bovine serum
albumin standards according to manufacturer’s instructions.
Samples were briefly heated to near boiling in SDS–PAGE
sample buffer and cleared of insoluble material by brief cen-
trifugation. Equal amounts of total protein from each sample
were resolved on 8% minigels by SDS–PAGE and transferred
to Immobilon-FL membranes (Millipore) (71). The mem-
branes were blocked overnight at 48C in Odyssey Blocking
Buffer (LI-COR) with continuous mixing and then incubated
with primary and secondary antibodies according to manufac-
turer’s instructions. Primary antibodies included mouse mono-
clonal anti-CaMKIIa (Affinity BioReagents, Cat. No.
MA1-048, 1:2500 dilution), mouse monoclonal anti-PSD-95
(Affinity BioReagents, Cat. No. MA1-048, 1:2500 dilution),
mouse monoclonal anti-Synaptophysin (Sigma-Aldrich, Cat.
No. S5768, 1:2500 dilution), rabbit polyclonal anti-synGAP
(Affinity BioReagents, Cat. No. PA1-046, 1:2500 dilution),
rabbit polyclonal anti-PSD-95 (custom made, Frances,
1:5000 dilution), mouse monoclonal anti-Htt (Chemicon,
Cat. No. MAB2166, 1:2500 dilution), mouse monoclonal
anti-clathrin heavy chain (Transduction Laboratories, Cat.
No. 610499, 1:2500 dilution), mouse monoclonal
anti-Importin-a2 (Transduction Laboratories, Cat. No.
610485, 1:5000 dilution), mouse monoclonal anti-HAP1
(Transduction Laboratories, Cat. No. 611302, 1:250 dilution);
rabbit polyclonal anti-NF-kB p65 (Santa Cruz Biotechnology,
Cat. No. sc-372, 1:1000 dilution), rabbit polyclonal
anti-NF-kB p50 (Santa Cruz Biotechnology, Cat. No.
sc-114, 1:1000 dilution), rabbit polyclonal anti-I-kBa (Santa
Cruz Biotechnology, Cat. No. sc-371, 1:500 dilution), mouse
monoclonal anti-I-kBa (Santa Cruz Biotechnology, Cat. No.
sc-1643, 1:500 dilution), rabbit polyclonal
anti-phospho-I-kBa S32 (Cell Signaling Technology, Cat.
No. 9241, 1:1,000 dilution), mouse monoclonal
anti-phospho-I-kBa S32/36 (Cell Signaling Technology, Cat.
No. 9246, 1:1000 dilution) and mouse monoclonal anti-Lamin
A/C (Cell Signaling Technology, Cat. No. 4777, 1:1000
dilution). Secondary antibodies included Alexa Fluor 680
goat-anti-rabbit or mouse IgG (Molecular Probes, 1:10 000
dilution) and IRDye 800 goat-anti-rabbit or mouse IgG
(Rockland Immunochemicals, 1:10 000 dilution). The All
Blue Precision Plus Protein (Bio-Rad) prestained standard
was used as molecular weight marker. For digital archiving
and quantitative analysis, the membranes were scanned with
an Odyssey dual-channel infrared scanner (LI-COR) using
the Odyssey image analysis software (LI-COR).
Immunoprecipitation
Fifty microliters of protein G magnetic beads (Dynabeads
Protein G, DYNAL/Invitrogen) were washed and coupled
with 5 mg of antigen-specific or isotype control antibody
according to manufacturer’s instructions. When required, the
antibody was cross-linked to the beads using disuccinimidyl
suberate (Pierce) according to manufacturer’s instructions.
Two hundred fifty micrograms of PSD fraction were solubil-
ized in 500 ml of DOC lysis buffer [50 mM Tris–HCl, pH
8.5, 1% sodium deoxycholate, 1× protease inhibitor cocktail
(Roche, Complete)] by incubation for 30 min at 378C and
then diluted with an equal volume of ice-cold Triton X-100
dilution buffer [50 mM Tris–HCl, pH 8.5, 2% Triton X-100,
1× protease inhibitor cocktail (Roche, Complete)]. In total,
107 HeLa cells were lysed in 1 ml of ice-cold NP-40 lysis
buffer [50 mM Tris–HCl, pH 7.5, 150 mM sodium chloride,
1% NP-40, 1× protease inhibitor cocktail (Sigma-Aldrich,
Cat. No. P8340)] by incubation for 30 min on ice with
occasional mixing. Insoluble material was removed by brief
centrifugation. Five hundred microliters of solubilized PSD
fraction or HeLa cell lysate were incubated with the beads
for at least 3 h at 48C with continuous mixing. The beads
were then washed four times with 1 ml of ice-cold lysis
buffer and once with 1 ml of ice-cold PBS using a magnetic
separation rack (New England BioLabs). The proteins bound
to the beads were eluted with 50 ml of SDS–PAGE sample
buffer and processed for immunoblotting as described above.
To quantify the amount of precipitated protein, the inte-
grated intensity of the fluorescent signal for p65 or
importin-a2 that immunoprecipitated with Htt was measured
with an Odyssey dual-channel infrared scanner and the
Odyssey image analysis software (LI-COR). These signals
were then normalized to the intensity of the Htt signal in the
same immunoprecipitate and compared under different exper-
imental conditions.
Enzyme-linked sorbent assay
To assess the interaction between Htt and PSD-95, we devel-
oped a fluorescent variant of the ELSA as follows. Human thior-
edoxin (TRX)-tagged Htt exon 1 fusion protein containing a
stretch of 16 glutamines and TRX-tag control protein were
expressed and purified as described in Bennett et al. (72). Full-
length rat His-tagged PSD-95 fusion protein was expressed and
purified as described in Korkin et al. (73). Purified TRX-tagged
Htt exon 1 (10 mg/ml in PBS) was added to the wells of an
Immulon-1B 96-well ELISA microplate (100 ml per well) in tri-
plicates. An equimolar amount of TRX-tag protein was used as
negative control. The plate was then incubated overnight at 48C
with gentle shaking to allow for adsorption of the ligand. After
adsorption, the wells were washed three times with 200 ml of
PBS and blocked overnight at 48C with 200 ml of Odyssey
Blocking Buffer (LI-COR). After blocking, the wells were
washed three times with 200 ml of PBS and various amounts
of purified PSD-95 were then added (100 ml per well, in
Odyssey Blocking Buffer diluted with an equal volume of
PBS) in triplicates and allowed to interact with the ligand for
3 h at room temperature. After binding, the wells were washed
three times with 200 ml of PBS + 0.1% Tween (PBS-Tw), the
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primary rabbit polyclonal antibody anti-PSD-95 (custom made,
Frances, 1:1000 dilution) was added (100 ml per well, in
Odyssey Blocking Buffer diluted with an equal volume of
PBS-Tw) and the plate was incubated for 1 h at room tempera-
ture. After incubation with the primary antibody, the wells were
washed three times with 200 ml of PBS-Tw, the secondary
Alexa Fluor 680 goat-anti-rabbit IgG antibody (Molecular
Probes, 1:2000 dilution) was added (100 ml per well, in
Odyssey Blocking Buffer diluted with an equal volume of
PBS-Tw) and the plate was incubated for 30 min at room temp-
erature. After incubation with the secondary antibody, the wells
were washed three times with 200 ml of PBS-Tw and once with
200 ml of PBS. The integrated intensity of the specific fluor-
escent signal was measured with an Odyssey dual-channel infra-
red scanner (LI-COR) using the Odyssey image analysis
software (LI-COR) and interpreted as directly indicative of
the amount of PSD-95 specifically bound to Htt exon 1. The
Kd of the interaction between PSD-95 and Htt exon 1 was calcu-
lated by curve fitting using the Prism software (GraphPad).
NF-kB DNA-binding assay
Neuronal nuclei were purified by OptiPrep (Axis-Shield, 60%
iodinaxol solution) and sucrose density gradient centrifugation
as follows. One mouse forebrain was homogenized in 2.4 ml
of ice-cold homogenization buffer [HB;20 mM Tricine–
KOH, pH 7.8, 0.25 M sucrose, 25 mM potassium chloride,
5 mM magnesium chloride, 1× protease inhibitor cocktail
(Roche, Complete EDTA-free)]. The homogenate was
adjusted to 6 ml with HB and mixed with 4 ml of 50% iodi-
naxol solution. The mixture was then centrifuged (10 000g)
for 30 min at 48C in a swinging-bucket rotor. The nuclear
pellet was resuspended in 2.4 ml of HB and centrifuged
(1000g) for 10 min at 48C. The nuclear pellet was enriched
for neuronal nuclei and the nuclear proteins were extracted
as described in Kaltschmidt et al. (20).
The DNA-binding activity of NF-kB in the nuclear extract
was analyzed by DNA pull-down assay as follows. Five
hundred micrograms of streptavidin magnetic beads (New
England BioLabs) were washed with 1 ml of buffer A
(20 mM Tris–HCl, pH 7.5, 0.5 M sodium chloride, 1 mM
EDTA) using a magnetic separation rack (New England
BioLabs). After washing, the beads were resuspended
in 50 ml of buffer A supplemented with 250 pmol of
biotinylated double-stranded DNA oligonucleotides (Inte-
grated DNA Technologies) containing a wild-type kB site
[5′-AGTTGAGGGGACTTTCCCAGGC-3′], and incubated
for 10 min at room temperature to allow for binding of the bio-
tinylated oligonucleotides to the streptavidin beads. An equal
amount of biotinylated oligonucleotides containing a mutant
kB site [5′-AGTTGAGGCGACTTTCCCAGGC-3′] was used
as negative control. The DNA-coated beads were then
washed three times with 1 ml of buffer A and incubated for
30 min at room temperature in 400 ml of buffer B [20 mM
Tris–HCl, pH 7.5, 20 mM sodium chloride, 1 mM dithiothrei-
tol] supplemented with 50 ng/ml poly(dI-dC) and 100 ml of
nuclear extract (1 mg/ml total protein concentration). The
beads were washed three times in 1 ml of buffer C [20 mM
Tris–HCl, pH 7.5, 100 mM sodium chloride, 1 mM dithiothrei-
tol, 5% glycerol] and the DNA-bound proteins were eluted
with 50 ml of SDS–PAGE sample buffer and processed for
immunoblotting as described above.
Live cell imaging and image analysis
Cultured neurons were made from single-sibling embryos and
one littermate pair (mutant and control) was imaged per exper-
iment (n ¼ 1) under identical conditions. Neuronal cultures
were pretreated for 12 h with 1 mM TTX to abolish action
potentials and silence network activity. Just before image
acquisition, the cultures were gently washed with HEPES-
buffered tyrode solution [10 mM HEPES–NaOH, pH 7.4,
110 mM sodium chloride, 10 mM glucose, 5.4 mM potassium
chloride, 1.8 mM calcium chloride, 0.8 mM magnesium chlor-
ide] prewarmed to 378C and in the absence of TTX to
induce synaptic activity. During image acquisition, the cul-
tures were maintained in HEPES-buffered tyrode solution at
378C using a heated incubation chamber fitted around the
microscope. Time-lapse images (frame size, 200 × 200
pixels; pixel size, 0.1 × 0.1 mm; pixel time: 2 ms) of
living, transiently transfected, cultured (15 days in vitro) cor-
tical pyramidal neurons were acquired as series of single
5 mm-thick optical sections at a frame rate of 0.66 Hz, using
an inverted laser-scanning confocal microscope (Zeiss, LSM
510 Meta NLO + Axiovert 200 M) equipped with a 63X/
1.4NA oil immersion objective (Zeiss, Plan-Apochromat).
paGFP–p65 and mCherry were excited using an Argon
(488 nm line) and HeNe (543 nm line) laser, respectively. A
Titanium:Sapphire near-IR tunable pulsed laser (Coherent,
Chameleon) was used for two-photon photoactivation of
paGFP–p65 at 750 nm. The green and red fluorescent emis-
sions were collected separately through a band-pass (500–
530 nm) and low-pass (560 nm) filter, respectively. Laser
power was kept at a minimum to minimize photobleaching
and photocytotoxicity. Images were acquired keeping the red
and green fluorescence signals within the dynamic range of
the instrument. Identical acquisition parameters and settings
were used for all image acquisitions in a given experiment.
Image acquisition was performed using the LSM 510 (Zeiss)
software, and image analysis was performed using the
ImageJ software (National Institutes of Health, http://rsb.
info.nih.gov/ij). The half-life (t1
2
) of the green fluorescence
intensity exponential decay within a region of interest was cal-
culated by curve fitting using the Prism software (GraphPad).
After live cell imaging, neurons were fixed with 4% formal-
dehyde in PBS for 5 min at room temperature and subjected
to the same routine outlined above.
Statistical analysis
All quantitative data were expressed as means+SEM. The
Student’s t-test (two-tailed, paired) was used for two group com-
parisons. A P-value of ,0.05 significance cut off was used.
SUPPLEMENTARY MATERIAL
Supplementary Material is available at HMG online.
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